Sanofi_Aventis_Genzyme.sff.jpg - Washington Times
Skip to content

FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)
Photo by: Michel Euler
FILE - In this Feb. 11, 2009 file photo, Chris Viehbacher CEO of Sanofi-Aventis SA, gestures while announcing the 2008 full year result in Paris. French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash deal that values the U.S. biotechnology company at $20.1 billion Wednesday, Feb. 16, 2011, ending months of corporate haggling. (AP Photo/Michel Euler, file)

Featured Photo Galleries

10302012_4_10302012_4_hires

Bizarre border busts

Photos from the U.S. Customs and Border Protection of the most bizarre attempts at smuggling drugs and people

Hayden Panettiere.jpg

Crazy Celebrity Tattoos

Tattoos are more popular than ever, but don’t let your kids get something like this. Check out the craziest tattoos celebrities have shown off and the ones they came to regret.